The WHO Prequalification Team announces that the Emergency Use Listing (EUL) will now be open to candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 (originally called 2019-nCoV). An invitation to manufacturers of IVDs to detect SARS-CoV-2 to submit an Expression of Interest (EOI) for assessment of candidate IVDs under the EUL procedure was issued on 28 February 2020:
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| WHO is calling manufacturers of mpox diagnostics to submit an expression of interest for Emergency Use Listing | 0 | 3 | August 29, 2024 | |
| Laboratories can obtain accurate and rapid results with Cepheid’s Xpert® Xpress SARS-CoV-2 Test: Webinar | 0 | 375 | April 14, 2020 | |
| WHO approves first mpox diagnostic test for emergency use, boosting global access | 0 | 6 | October 3, 2024 | |
| Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test | 0 | 704 | September 30, 2020 | |
| To Improve Access To Diagnostics, Countries Must Adapt The WHO Essential Diagnostics List | 0 | 485 | February 1, 2021 |